Adam C. ElNaggar
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 24
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 9
-
- Cancer Genomics and Diagnostics 19
- Oncology top 10%
- PARP inhibition in cancer therapy 7
-
- BRCA gene mutations in cancer 8
-
- Renal cell carcinoma treatment 5
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Intraperitoneal and Appendiceal Malignancies 5
- Co-authors
- David E. CohnJoseph T. SantosoPeriannan KuppusamyJohn L. HaysTodd TillmannsChelsea BolyardAdrian A. SuarezKristin Bixel
- Journals
- Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Adam C. ElNaggar
59 papers receiving 576 citations
Peers
Comparison fields: 5 of 69
- Reproductive Medicine 131
- Obstetrics and Gynecology 76
- Cancer Research 133
- Oncology 238
- Pathology and Forensic Medicine 95
Countries citing papers authored by Adam C. ElNaggar
This map shows the geographic impact of Adam C. ElNaggar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam C. ElNaggar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam C. ElNaggar more than expected).
Fields of papers citing papers by Adam C. ElNaggar
This network shows the impact of papers produced by Adam C. ElNaggar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam C. ElNaggar. The network helps show where Adam C. ElNaggar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam C. ElNaggar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 26 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 4 | |
| 13 | 2018 | 12 | |
| 14 | 2016 | 4 | |
| 15 | 2016 | 3 | |
| 16 | 2016 | 96 | |
| 17 | 2015 | 8 | |
| 18 | 2014 | 76 | |
| 19 | 2014 | 1 | |
| 20 | 2011 | 5 |
About Adam C. ElNaggar
Adam C. ElNaggar is a scholar working on Reproductive Medicine, Cancer Research and Obstetrics and Gynecology, having authored 68 papers that have together received 579 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (24 papers), Cancer Genomics and Diagnostics (19 papers), Endometrial and Cervical Cancer Treatments (9 papers), BRCA gene mutations in cancer (8 papers), PARP inhibition in cancer therapy (7 papers), Renal cell carcinoma treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). The work is most often cited by research in Reproductive Medicine (131 citations), Obstetrics and Gynecology (76 citations) and Cancer Research (133 citations). Adam C. ElNaggar has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David E. Cohn, Joseph T. Santoso, Periannan Kuppusamy, John L. Hays, Todd Tillmanns, Chelsea Bolyard, Adrian A. Suarez, Kristin Bixel, K. Selvendiran and John Wallbillich. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.